RxDoctor Payments Data

Bridget Cervantes, PA

Physician Assistant · Scottsdale, AZNPI 1871264366

Payments from drug & device makers

$3,737in general payments, 2019–2025

Across 137 payments — averaging $27.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Takeda Pharmaceuticals U.S.A., Inc.$1K
  • E.r. Squibb & Sons, L.L.C.$221
  • Johnson & Johnson$183
  • Intercept Pharmaceuticals, Inc.$179
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$174
  • plus $875 from 16 others

What the payments were for

  • Food & beverage$3,737100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,737 in reported general payments places this provider in the 85th percentile of 2,888 physician assistant providers in Arizona.

See all physician assistant providers in Arizona

Medicare billing

Part B allowed, 2024
$50,830
Medicare patients
407
Services billed
547

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
IbsrelaTenapanor Hcl22$44,410
LinzessLinaclotide46$33,232
XifaxanRifaximin12$24,428
TrulancePlecanatide18$10,877
Lubiprostone14$3,153
Pantoprazole Sodium112$1,707
Dicyclomine Hcl61$1,616
Omeprazole91$1,288
Lansoprazole11$1,214
Famotidine59$908
Esomeprazole Magnesium11$651
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl29$486
Promethazine Hcl19$373
Ondansetron OdtOndansetron18$288
Paroxetine Hcl11$164

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Ardelyx, Inc.Ibsrela$68$44,41022 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance$174$35,30430 claims
AbbVieLinzess$1,066$33,23246 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,888 physician assistant providers in Arizona.

Other physician assistant in Scottsdale

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →